Cisplatin: synthesis, antitumour activity and mechanism of action.
about
Tandem mass spectrometry for characterization of covalent adducts of DNA with anticancer therapeuticsGermline stem cell gene PIWIL2 mediates DNA repair through relaxation of chromatinRapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications.Tumor suppression by p53: making cells senescent.Silymarin selectively protects human renal cells from cisplatin-induced cell death.Platinum drug-DNA interactions in human tissues measured by cisplatin-DNA enzyme-linked immunosorbent assay and atomic absorbance spectroscopy.Engineered tumor cell apoptosis monitoring method based on dynamic laser tweezersNanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin.Platinum antitumour agents: a review of (bio)analysis.Comparative In Vitro Binding Studies of TiCl2(dpme)2, Ti(ada)2(bzac)2, and TiCl2(bzac)(bpme) Titanium Complexes with Calf-Thymus DNA.Matrix-assisted laser desorption ionization time-of-flight mass spectrometry of DNA-Pt(II) complexes.Dysregulation of purine nucleotide biosynthesis pathways modulates cisplatin cytotoxicity in Saccharomyces cerevisiae.Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer.Design, Synthesis of Novel Platinum(II) Glycoconjugates, and Evaluation of Their Antitumor Effects.Dimethyl sulfoxide inactivates the anticancer effect of cisplatin against human myelogenous leukemia cell lines in in vitro assays.Mixed ligand-silver(I) complexes with anti-inflammatory agents which can bind to lipoxygenase and calf-thymus DNA, modulating their function and inducing apoptosis.Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro.Cisplatin cytotoxicity is dependent on mitochondrial respiration in Saccharomyces cerevisiae.Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender DifferencesMitochondrial density determines the cellular sensitivity to cisplatin-induced cell death.Protective role of Emblica officinalis hydro-ethanolic leaf extract in cisplatin induced nephrotoxicity in Rats.
P2860
Q28486298-9C571D84-0A32-4E73-BF55-E8A0EACAD185Q28593830-E1909DA9-9C51-4926-B5E7-84AF6AD6BE70Q33553311-B2B23CD5-FB56-49C1-A2A1-6053B7DA0825Q33736728-E4C510E8-7171-496F-8C47-CAB1D02FA162Q33904503-ABD1EB10-4888-455D-9AE8-358453EE4C97Q35031455-D148C331-CE42-488E-B99E-D30B9C827101Q35163497-DF0C7A43-184B-4C54-94A0-07D3611AE45FQ36217643-5A33078C-C8FA-4C39-BE94-D7EC7943D591Q36322728-D6704790-D6BC-41C4-ACCC-5BA119E00F20Q36457231-F629CFE1-86C2-4D98-B3C5-DAA529EEC1E1Q36719403-197D2CA0-718D-4BA8-9526-82737E014DDEQ36952570-0E11FE1B-A4E0-4B76-B44E-A6F2263FB8BFQ37803144-B222A054-F417-4F06-BDBB-A24B68256F07Q38808998-EA8FC5D7-2F58-4311-AB0D-2C1EC9B508B8Q38864648-92F77A8A-33FD-42EE-8F79-BD90D7BCA6FCQ39354958-90A696B7-2C78-4170-A392-D4ED860C714AQ40432082-2BD909FB-2F21-45BE-B0D6-2F11D4CBCB4DQ42202353-630B6803-FF33-4658-8F88-D5CE3B00DAEDQ42329874-D5946542-D165-46BA-B8D4-A4E2C2D9D8E9Q42343539-4ED84565-B666-4E5A-8576-FA6BB1A30885Q46656360-E9C25596-E8F2-4132-AE5A-53B380A9AD10Q50308847-920E379B-5EE9-423A-A9AB-ECB30EA9D08D
P2860
Cisplatin: synthesis, antitumour activity and mechanism of action.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Cisplatin: synthesis, antitumour activity and mechanism of action.
@en
Cisplatin: synthesis, antitumour activity and mechanism of action.
@nl
type
label
Cisplatin: synthesis, antitumour activity and mechanism of action.
@en
Cisplatin: synthesis, antitumour activity and mechanism of action.
@nl
prefLabel
Cisplatin: synthesis, antitumour activity and mechanism of action.
@en
Cisplatin: synthesis, antitumour activity and mechanism of action.
@nl
P356
P1476
Cisplatin: synthesis, antitumour activity and mechanism of action.
@en
P2093
P304
P356
10.1007/BF02307573
P577
1985-10-01T00:00:00Z